Their big money maker is the internal product. Which may technically be named AC5 - or something similar. They also have many other patents - as you referenced. But the money is in the internal surgery product. And it has shown to work in animals when you cut into them. But. They need human trials. Which will come after the approval of the external AC5. Which was the reason they just raised all of that money a month ago. As has been said before here - it is easy to get products approved for animal use. Quite another for human use. The standards are different and the cost of the testing and studies is exponentially higher. Approval of the internal use product not only will explode the stock price - but it will also show the potential of getting the other patents approved. So Yes - most of their money has been invested in Research and Development. Now they are going into the execution phase. We will see - but I remain optimistic.
News 
Market Data 
Discover 
